Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Odyssey Therapeutics, Inc. (ODTX)

$18.66 +5.60% NASDAQ: ODTX · 15-min delayed
  • BOSTON, Massachusetts
  • Public · NASDAQ: ODTX
$775.1MMarket cap
ODTXNASDAQ
2026IPO

About Odyssey Therapeutics, Inc.

Odyssey Therapeutics Inc is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases. The Company is developing medicines that are designed to precisely target disease pathology with an initial emphasis on the innate immune system. Its programs include OD-07656, a small molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, a small molecule scaffolding inhibitor of interleukin-1 receptor-associated kinase 4, or IRAK4, and OD-00910, an agonistic protein therapeutic targeting tumor necrosis factor receptor 2, or TNFR2, built from camelid heavy chain variable regions, or VHH, domains.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Market cap
$775.1M
NASDAQ: ODTX
$18.66 +5.60%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$15.56 $19.07

52-week range

Market cap
$775.1M
Shares outstanding
41.5M
Open
Day range
Prev close
Volume
IPO date
May 8, 2026

Odyssey Therapeutics, Inc. (ODTX) Stock Price

  • Trading near its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Odyssey Therapeutics, Inc..

Write a review
FAQ

Odyssey Therapeutics, Inc.: frequently asked questions

Is Odyssey Therapeutics, Inc. an American company?

Odyssey Therapeutics, Inc. is a US-based company headquartered in Boston, Massachusetts, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Odyssey Therapeutics, Inc. headquartered?

Odyssey Therapeutics, Inc. is headquartered in Boston, Massachusetts, United States.

Is Odyssey Therapeutics, Inc. publicly traded?

Yes — Odyssey Therapeutics, Inc. is a publicly traded company. Its stock trades under the ticker symbol ODTX on the NASDAQ.

What does Odyssey Therapeutics, Inc. do?

Odyssey Therapeutics, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore

Similar companies

Browse all →